BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Beas J, Guadix JA, Clares B, Soriano-Ruiz JL, Zugaza JL, Gálvez-Martín P. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient. Med Res Rev 2020;40:1315-34. [PMID: 32017179 DOI: 10.1002/med.21659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sanchez-Castro EE, Pajuelo-Reyes C, Tejedo R, Soria-Juan B, Tapia-Limonchi R, Andreu E, Hitos AB, Martin F, Cahuana GM, Guerra-Duarte C, de Assis TCS, Bedoya FJ, Soria B, Chávez-Olórtegui C, Tejedo JR. Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming. Front Immunol 2020;11:609961. [PMID: 33633730 DOI: 10.3389/fimmu.2020.609961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F, Liu C, Liu J, Luo Y. A Brief Overview of Global Trends in MSC-Based Cell Therapy. Stem Cell Rev Rep 2022. [PMID: 35344199 DOI: 10.1007/s12015-022-10369-1] [Reference Citation Analysis]
3 Pleguezuelos-beltrán P, Gálvez-martín P, Nieto-garcía D, Marchal JA, López-ruiz E. Advances in spray products for skin regeneration. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.02.023] [Reference Citation Analysis]
4 Kasai Y, Morino T, Dobashi I, Mori E, Yamamoto K, Kojima H. Temporary Storage of the Human Nasal Tissue and Cell Sheet for Wound Repair. Front Bioeng Biotechnol 2021;9:687946. [PMID: 34368095 DOI: 10.3389/fbioe.2021.687946] [Reference Citation Analysis]
5 Jimenez-Puerta GJ, Marchal JA, López-Ruiz E, Gálvez-Martín P. Role of Mesenchymal Stromal Cells as Therapeutic Agents: Potential Mechanisms of Action and Implications in Their Clinical Use. J Clin Med 2020;9:E445. [PMID: 32041213 DOI: 10.3390/jcm9020445] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
6 Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maurício AC. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics 2022;14:381. [DOI: 10.3390/pharmaceutics14020381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nieto D, Jiménez G, Moroni L, López-Ruiz E, Gálvez-Martín P, Marchal JA. Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology. Med Res Rev 2022. [PMID: 35707911 DOI: 10.1002/med.21914] [Reference Citation Analysis]
8 Wang LT, Liu KJ, Sytwu HK, Yen ML, Yen BL. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med 2021;10:1288-303. [PMID: 34008922 DOI: 10.1002/sctm.21-0021] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Muthu S, Jeyaraman M, Kotner MB, Jeyaraman N, Rajendran RL, Sharma S, Khanna M, Rajendran SNS, Oh JM, Gangadaran P, Ahn BC. Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)-An Indian Perspective. Bioengineering (Basel) 2022;9:111. [PMID: 35324800 DOI: 10.3390/bioengineering9030111] [Reference Citation Analysis]